BRIEF-Teva reports FDA acceptance of resubmitted NDA for SD-809 By: Reuters: Company News October 20, 2016 at 09:12 AM EDT * Teva announces FDA acceptance of resubmitted new drug application for SD-809 for treatment of Chorea associated with Huntington disease Read More >> Related Stocks: Teva Pharmaceutical Industries ADR